Arterial Remodeling Technologies (“ART”) Reports First Human Use of Its Next-Generation Bioresorbable Stent
09:17 EDT 16 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Arterial
Remodeling Technologies (“ART”) reported today that the Company has
achieved a medical milestone with its “ARTDIVA” (Arterial Remodeling
Transient DIsmantling Vascular Angioplasty)
clinical trial: the suc...
Other Sources for this Article
Ronald Trahan Associates Inc.
Ronald Trahan, APR, 508-359-4005, x108
More From BioPortfolio on "Arterial Remodeling Technologies (“ART”) Reports First Human Use of Its Next-Generation Bioresorbable Stent"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
